...
首页> 外文期刊>Journal of hypertension >Role of angiotensin II in L-NAME-induced systemic and renal hemodynamic effects in hydrochlorothiazide-pretreated hypertensive subjects.
【24h】

Role of angiotensin II in L-NAME-induced systemic and renal hemodynamic effects in hydrochlorothiazide-pretreated hypertensive subjects.

机译:在氢氯噻嗪预处理的高血压受试者中,血管紧张素II在L-NAME诱导的全身和肾脏血液动力学效应中的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Experimental evidence suggests that in conditions associated with an activated renin-angiotensin system, unopposed activity of angiotensin II underlies the marked renal vasoconstrictor response to nitric oxide synthase inhibition. In the present study, we investigated whether this holds true in hypertensive subjects pretreated with hydrochlorothiazide (HCT). METHODS: Systemic N(G)-nitro-L-arginine methyl ester (L-NAME) infusions (12.5 microg/kg per min for 40 min) were given to eight hypertensive subjects (age 53 +/- 6 years) during placebo, and during pretreatment with HCT (25 mg once daily) or HCT and losartan (LOS) (50 mg twice daily), both for 9 days. The glomerular filtration rate (GFR) and renal plasma flow were estimated from the clearances of radiolabeled thalamate and hippuran. Renal blood flow (RBF) was calculated as renal plasma flow/1 - hematocrit and the renal vascular resistance (RVR) as mean arterial pressure (MAP) divided by RBF. RESULTS: Compared with placebo, plasma renin increased (P < 0.001) from 15 +/- 4 mU/l during placebo to 26 +/- 7 mU/l during HCT and to 133 +/- 51 mU/l during HCT + LOS. MAP (110 +/- 3 mmHg) decreased to 102 +/- 4 mmHg during HCT and to 98 +/- 5 mmHg during HCT + LOS. RBF (579 +/- 36 ml/min), GFR (97 +/- 6 ml/min) and filtration fraction (29 +/- 2%) did not change, whereas RVR (200 +/- 15 RU) decreased to 183 +/- 13 RU during HCT and to 165 +/- 14 RU during HCT + LOS (P < 0.05). In response to L-NAME, MAP and RVR increased maximally by 10 +/- 3 and 67 +/- 9%, whereas RBF and GFR decreased maximally by 42 +/- 6 and 18 +/- 4%. Compared with these responses, the responses of MAP, RBF and RVR were not affected by pretreatment of HCT or HCT + LOS, but the L-NAME-induced decrease in GFR (26 +/- 5% during HCT and 29 +/- 5% during HCT and LOS) was enhanced (P < 0.01). CONCLUSIONS: In hypertensive subjects with an activated renin-angiotensin system, unopposed activity of angiotensin II is not involved in L-NAME-induced pressor and renal vasoconstrictor response,whereas the L-NAME-induced decrease in GFR is enhanced, indicating greater dependency of GFR on nitric oxide-mediated vasodilator tone during sodium depletion.
机译:背景:实验证据表明,在与激活的肾素-血管紧张素系统相关的情况下,血管紧张素II的无抵抗活性是对一氧化氮合酶抑制作用明显的肾脏血管收缩反应的基础。在本研究中,我们调查了在氢氯噻嗪(HCT)预处理的高血压受试者中这是否成立。方法:在安慰剂治疗期间,对8位高血压受试者(年龄为53 +/- 6岁)进行了全身性N(G)-硝基-L-精氨酸甲酯(L-NAME)输注(每分钟12.5微克/千克,持续40分钟),在用HCT(每天25 mg,每天一次)或HCT和氯沙坦(LOS)(50 mg,每天两次)进行预处理的过程中,均为9天。肾小球滤过率(GFR)和肾血浆流量是根据放射性标记的丘脑和马尿苷的清除率估算的。肾血流量(RBF)计算为肾血浆流量/ 1-血细胞比容,肾血管阻力(RVR)计算为平均动脉压(MAP)除以RBF。结果:与安慰剂相比,血浆肾素从安慰剂期间的15 +/- 4 mU / l增加到HCT期间的26 +/- 7 mU / l和HCT + LOS期间的133 +/- 51 mU / l(P <0.001) 。 MAP(110 +/- 3 mmHg)在HCT期间降至102 +/- 4 mmHg,在HCT + LOS期间降至98 +/- 5 mmHg。 RBF(579 +/- 36 ml / min),GFR(97 +/- 6 ml / min)和过滤率(29 +/- 2%)不变,而RVR(200 +/- 15 RU)降至HCT期间为183 +/- 13 RU,HCT + LOS期间为165 +/- 14 RU(P <0.05)。响应L-NAME,MAP和RVR最大增加了10 +/- 3和67 +/- 9%,而RBF和GFR最大减少了42 +/- 6和18 +/- 4%。与这些响应相比,MAP,RBF和RVR的响应不受HCT或HCT + LOS预处理的影响,但L-NAME诱导的GFR降低(HCT期间为26 +/- 5%,HCT期间为29 +/- 5 HCT和LOS期间的%升高(P <0.01)。结论:在具有激活的肾素-血管紧张素系统的高血压受试者中,血管紧张素II的无抵抗活性不参与L-NAME引起的升压和肾血管收缩反应,而L-NAME引起的GFR降低增加,表明对GFR的依赖性更大钠耗竭期间GFR对一氧化氮介导的血管舒张作用的调节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号